1,662 results match your criteria: "Universitaire de Toulouse[Affiliation]"

Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.

Mol Cancer

January 2023

Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.

Article Synopsis
  • Scientists found that certain changes in genes can cause cancer, specifically in a type called T-cell acute lymphoblastic leukemia (T-ALL).
  • They discovered that a specific mutation in a gene (TAL1) signals which patients might have a worse outcome, regardless of other gene activity.
  • Mebendazole, a medicine, can help treat T-ALL by breaking down a protein linked to the mutation, showing that new treatments could be developed targeting these genetic issues.
View Article and Find Full Text PDF

The rod-shaped adult cardiomyocyte (CM) harbors a unique architecture of its lateral surface with periodic crests, relying on the presence of subsarcolemmal mitochondria (SSM) with unknown role. Here, we investigated the development and functional role of CM crests during the postnatal period. We found in rodents that CM crest maturation occurs late between postnatal day 20 (P20) and P60 through both SSM biogenesis, swelling and crest-crest lateral interactions between adjacent CM, promoting tissue compaction.

View Article and Find Full Text PDF

Background: A new population of older people is growing: the oldest-old. The care of the oldest-old (individuals aged 90 and over) is a new challenge in primary care. This study aimed to analyze the perception of General Practitioners (GP) on (1) the aging process of their patients up to a very advanced age, (2) how to adapt their practice to the care of these patients.

View Article and Find Full Text PDF

Background: Since 1990's, the cognitive profile of children with a neurofibromatosis type 1 (NF1) has been refined by many different studies. Children with NF1 may exhibit a variety of cognitive dysfunctions. Memory difficulties have been reported, but the results are contradictory and, compared to other cognitive functions, memory has been less evaluated.

View Article and Find Full Text PDF

Time to steroids impacts visual outcome of optic neuritis in MOGAD.

J Neurol Neurosurg Psychiatry

April 2023

Service de neurologie, Hôpital de la Timone, APHM, Marseille, France.

Background: To characterise the response to treatment of inaugural optic neuritis (ON) in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

Methods: We searched the French MOGAD database for adults with inaugural ON with a detailed report of acute treatment modalities and measures of high-contrast best-corrected visual acuity (BCVA) at nadir and after 3 months. Predictors of visual outcomes were assessed by multivariable analysis.

View Article and Find Full Text PDF

Introduction: The World Health Organisation recently defined the construct of intrinsic capacity (IC), a function-based marker of older adult's health encompassing all mental and physical capacities of the individual. Multicomponent physical exercise (MCE) is a potential intervention capable to maintain/increase IC at older age; however, evidence is scarce on the effects of MCE on IC in cognitively impaired pre-frail/frail older adults.

Methods: Secondary analyses of a randomised clinical trial.

View Article and Find Full Text PDF

Cross-sectional and prospective associations between homocysteine and a frailty index: A post-hoc analysis of the multidomain Alzheimer's prevention trial (MAPT).

Exp Gerontol

February 2023

Gérontopôle de Toulouse, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, 37 allée Jules Guesdes, 31000 Toulouse, France; UMR INSERM, 1295 University of Toulouse III, Faculté de médecine, 37 allées Jules Guesde, 31000 Toulouse, France.

Background: Homocysteine (Hcy) has been associated with several health problems, including reduced physical capacity. No study appears to have looked at the role of Hcy values longitudinally on physical capacity deterioration in older adults. The objective is to examine cross-sectional and prospective associations between Hcy values and frailty in the elderly and investigate Hcy potential association with the onset of frailty.

View Article and Find Full Text PDF
Article Synopsis
  • Gilteritinib, a type of medicine for a serious blood cancer called FLT3-mutated acute myelogenous leukemia (AML), helped patients live longer in a study called the ADMIRAL trial.
  • In the trial, some patients received gilteritinib, while others had different chemotherapy treatments, and those who did well could get gilteritinib again after a stem cell transplant.
  • Overall, patients who took gilteritinib had better chances of going through a successful transplant and experienced lower relapse rates compared to those on chemotherapy.
View Article and Find Full Text PDF

Overlapping features of therapy-related and de novo NPM1-mutated AML.

Blood

April 2023

Institute of Hematology and Center for Hemato-Oncology Research (CREO), Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.

NPM 1-mutated acute myeloid leukemia (AML) shows unique features. However, the characteristics of "therapy-related" NPM1-mutated AML (t-NPM1 AML) are poorly understood. We compared the genetics, transcriptional profile, and clinical outcomes of t-NPM1 AML, de novo NPM1-mutated AML (dn-NPM1 AML), and therapy-related AML (t-AML) with wild-type NPM1 (t-AML).

View Article and Find Full Text PDF

The haemagglutination test (HAT)-field protocol described here is an optimization of the recently published HAT, for the detection of antibodies directed against the receptor binding domain (RBD) of the SARS-Cov-2 virus. HAT and HAT-field are both based on haemagglutination triggered by a single reagent, the IH4-RBD recombinant protein. A sample of IH4-RBD sufficient for several thousand tests or a plasmid encoding IH4-RBD can be obtained from the authors of our first paper.

View Article and Find Full Text PDF

Objectives: A frequent late Alzheimer's Disease and Related Diseases (ADRD) identification is described and may induce erratic health resource use. We aimed to describe healthcare use patterns preceding ADRD identification.

Methods: We studied persons aged 65 or older, identified with incident ADRD in 2012 in the French health insurance database.

View Article and Find Full Text PDF

Sedentary behavior and the biological hallmarks of aging.

Ageing Res Rev

January 2023

Gérontopôle de Toulouse, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, 37 Allées Jules Guesdes, 31000 Toulouse, France; CERPOP UMR 1295, University of Toulouse III, Inserm, UPS, Toulouse, France.

While the benefits of physical exercise for a healthy aging are well-recognized, a growing body of evidence shows that sedentary behavior has deleterious health effects independently, to some extent, of physical activity levels. Yet, the increasing prevalence of sedentariness constitutes a major public health issue that contributes to premature aging but the potential cellular mechanisms through which prolonged immobilization may accelerate biological aging remain unestablished. This narrative review summarizes the impact of sedentary behavior using different models of extreme sedentary behaviors including bedrest, unilateral limb suspension and space travel studies, on the hallmarks of aging such as genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication.

View Article and Find Full Text PDF

A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome.

Int J Infect Dis

December 2022

Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France. Electronic address:

A patient aged 28 years who is immunocompromised and living with HIV/AIDS became infected with the monkeypox virus (MPXV). His clinical condition deteriorated for 37 days, with fever, skin lesions, and diarrhea before going to the infectious diseases department, where his severe, protracted infection was treated with tecovirimat for 14 days. His condition rapidly improved, and the skin lesions decreased, as did the MPXV loads, with no adverse events.

View Article and Find Full Text PDF
Article Synopsis
  • A study assessed the safety and efficacy of gilteritinib in 167 patients with relapsed/refractory FLT3-mutated acute myeloid leukemia (AML), comparing it to data from the ADMIRAL trial.
  • The key differences in patient characteristics included higher rates of poor performance status and FLT3-TKD mutations, along with more complex treatment histories among participants.
  • The results showed similar rates of complete remission and overall survival between treatment cohorts and highlighted the potential for outpatient treatment benefits for heavily pretreated patients.
View Article and Find Full Text PDF

Machine learning-based scoring system to predict in-hospital outcomes in patients hospitalized with COVID-19.

Arch Cardiovasc Dis

December 2022

Université de Paris, PARCC, INSERM, 75015 Paris, France; Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France.

Background: The evolution of patients hospitalized with coronavirus disease 2019 (COVID-19) is still hard to predict, even after several months of dealing with the pandemic.

Aims: To develop and validate a score to predict outcomes in patients hospitalized with COVID-19.

Methods: All consecutive adults hospitalized for COVID-19 from February to April 2020 were included in a nationwide observational study.

View Article and Find Full Text PDF

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.

Neurol Neuroimmunol Neuroinflamm

January 2023

From the Unité de Recherche Clinique Cote d'Azur-UR2CA URRIS (M.L., C.L.-F.), Centre Hospitalier Universitaire de Nice; Département de Biostatistiques (S.L.-C.), Epidémiologie clinique et Santé Publique, Centre Hospitalier Universitaire de Nîmes; Département de Neurologie (X.A., P.L.), Centre Hospitalier Universitaire de Montpellier, Montpellier; Département de Neurologie (K.B., J.D.S.), Centre Hospitalier Universitaire de Strasbourg; Service de Neurologie (M.R., E.T.), Centre Hospitalier Universitaire de Nîmes; Laboratoire de Biochimie (S.S.), Centre Hospitalier Universitaire de Nîmes; Département de Neurologie (H.Z., T.A.), Centre Hospitalier Universitaire de Lille; Centre Hospitalier Universitaire de Lille (J.-D.P.), Service de Biochimie Automatisée, Protéines (UF 8833), Lille; Département de Neurologie (J.C., D.B.), Centre Hospitalier Universitaire de Toulouse, Hôpital Pierre-Paul Riquet, CRC-SEP, F-31059, Toulouse Cedex 9; Laboratoire d'Immunologie (B.P.-L.), Centre Hospitalier Universitaire de Toulouse; Département de Neurologie (J.-P.C.), Centre Hospitalier Universitaire de Saint-Etienne; Laboratoire de Biochimie (Y.T.), Centre Hospitalier Universitaire de Saint-Etienne; Département de Neurologie (O.C.), Centre Hospitalier Universitaire de Grenoble Alpes; Univ. Grenoble Alpes (B.T.), CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC; Laboratoire de Biochimie (B.T., J.M.), Centre Hospitalier Universitaire de Grenoble Alpes; Département de Neurologie (T.M.), Centre Hospitalier de Dijon; Laboratoire de Biochimie (D.L., A.T.), Centre Hospitalier Universitaire de Dijon; Département de Neurologie (E.M.), Assistance-Publique des Hôpitaux de Paris, Centre Hospitalier Universitaire de la Pitié-Salpêtrière; Laboratoire d'Immunologie (D.S.), Assistance Publique des Hôpitaux de Paris, Centre Hospitalier Universitaire de la Pitié-Salpêtrière, Paris; Département de Neurologie (A.M., A.R.), Centre Hospitalier Universitaire de Tours; Université de Nantes (D.A.L.), C2RTI Inserm UMR1064, service de Neurologie, CHU Nantes; Département de Biochimie (E.B.-C., P.-O.B.), Centre Hospitalier Universitaire de Nantes; Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie; Laboratoire de Biochimie (J.B.), Assistance Publique des Hôpitaux de Marseille, Centre Hospitalier Universitaire de La Conception; Laboratoire d'Immunologie (T.V.), Centre Hospitalier Universitaire de Montpellier; Laboratoire d'Immunologie (I.J.), Centre Hospitalier Universitaire Strasbourg; Laboratoire d'Immunologie (B.S.-P.), Centre Hospitalier Universitaire de Nice; Institut de Génomique Fonctionnelle (E.T.), Université de Montpellier, CNRS, INSERM, Montpellier; and Département de Neurologie (C.L.-F.), Centre Hospitalier Universitaire de Nice, France.

Background And Objectives: Kappa free light chains (KFLC) seem to efficiently diagnose MS. However, extensive cohort studies are lacking to establish consensus cut-offs, notably to rule out non-MS autoimmune CNS disorders. Our objectives were to (1) determine diagnostic performances of CSF KFLC, KFLC index, and KFLC intrathecal fraction (IF) threshold values that allow us to separate MS from different CNS disorder control populations and compare them with oligoclonal bands' (OCB) performances and (2) to identify independent factors associated with KFLC quantification in MS.

View Article and Find Full Text PDF

Invasive pneumococcal infections in France: Changes from 2009 to 2021 in antibiotic resistance and serotype distribution of Streptococcus pneumoniae based on data from the French Regional Pneumococcal Observatories network.

Infect Dis Now

February 2023

Observatoire Régional du Pneumocoque Pays-de-la-Loire, Centre Hospitalier Universitaire d'Angers, Département de Biologie des Agents Infectieux, Laboratoire de Bactériologie, Angers, France; Nantes Université, Angers Université, INSERM, CNRS, INCIT, UMR 1302/EMR6001, équipe ATOMycA, France. Electronic address:

Objective: The 23 French Regional Pneumococcal Observatories (ORPs) analyzed antibiotic resistance and serotypes of Streptococcus pneumoniae strains isolated from invasive infections in France over a 12-year period.

Methods: Between 2009 and 2021, the ORPs analyzed 19,319 strains, including 1,965 in children and 17,354 in adults. Strains were assessed for their resistance to penicillin G, amoxicillin and cefotaxime.

View Article and Find Full Text PDF

Periostin, involved in extracellular matrix development and support, has been shown to be elevated in senescent tissues and fibrotic states, transversal signatures of aging. We aimed to explore associations between plasma periostin and physical and cognitive capacity evolution among older adults. Our hypothesis was that higher levels of plasma periostin will be associated with worse physical and mental capacities along time.

View Article and Find Full Text PDF

Mitochondrial dysfunction occurs during aging and may play a role, by distinct mechanisms, in the loss of intrinsic capacity (IC), operationalized through 5 domains: locomotion, psychological, cognition, vitality/nutrition, and sensory (hearing, vision). The objective of this review is to provide an overview of the associations between mitochondrial function and IC domains. This study is a narrative review of original investigations (any study design) on the relationship of mitochondrial function in humans with locomotion (eg, gait speed), psychological (eg, depressive symptoms), cognition (eg, global cognitive function), vitality (eg, handgrip strength), and/or sensory (hearing and vision acuity) domains.

View Article and Find Full Text PDF

Background: Olutasidenib (FT-2102) is a potent, selective, oral, small-molecule inhibitor of mutant isocitrate dehydrogenase 1 (IDH1). The aims for phase 1 of this phase 1/2 study were to assess the safety, pharmacokinetics, pharmacodynamics, and clinical activity of olutasidenib, as monotherapy or in combination with azacitidine, in patients with acute myeloid leukaemia or myelodysplastic syndrome, harbouring mutant IDH1.

Methods: In this phase 1/2, multicentre, open-label clinical trial, we enrolled patients aged 18 years or older with acute myeloid leukaemia or intermediate, high, or very high risk myelodysplastic syndrome harbouring mutant IDH1 at 18 study sites in the USA, Australia, France, and Spain.

View Article and Find Full Text PDF

Background: Intravenous alteplase is the only thrombolytic treatment approved for patients with acute ischemic stroke (AIS). Although no randomized controlled trial (RCT) has shown the superiority of tenecteplase over alteplase in AIS, tenecteplase is increasingly used off-label in Stroke Units. The purpose of the present work was to provide an up-to-date set of expert consensus statements on the use of tenecteplase in AIS.

View Article and Find Full Text PDF

Background: Structural and biochemical changes in stored platelets are influenced by collection and processing methods. Lesions may appear during platelet concentrate storage, some of which may be involved in adverse transfusion reactions. The preparation and storage of platelet concentrates (PC) may modify and even damage the lipid mediator content.

View Article and Find Full Text PDF

IgA Vasculitis Following COVID-19 Vaccination: A French Multicenter Case Series Including 12 Patients.

J Rheumatol

February 2023

Y. Ramdani, MD, F. Maillot, MD, PhD, A. Audemard-Verger, MD, PhD, Department of Internal Medicine and Clinical Immunology, CHRU de Tours, and Université de Tours, Tours;

Objective: The worldwide coronavirus disease 2019 (COVID-19) vaccination campaign triggered several autoimmune diseases. We hereby aimed to describe IgA vasculitis (IgAV) following COVID-19 vaccination.

Methods: We conducted a national, multicenter, retrospective study in France of new-onset adult IgAV diagnosis following COVID-19 vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • Acute myeloid leukemia (AML) is linked to leukemic stem cells (LSC), which affect patient responses to chemotherapy and overall survival, highlighting the importance of measuring LSC levels.
  • A study evaluated 155 AML patients post-chemotherapy to assess the effectiveness of detecting measurable residual disease (MRD) in both bulk and LSC populations, using unsupervised clustering methods.
  • Results showed a significant difference in overall survival rates between patients with positive MRD and those who tested negative, with some patients having negative Bulk MRD but positive LSC MRD, indicating these individuals have an intermediate prognosis.
View Article and Find Full Text PDF